Literature DB >> 29107084

Evidence for M2 macrophages in granulomas from pulmonary sarcoidosis: A new aspect of macrophage heterogeneity.

Masoud Shamaei1, Esmaeil Mortaz2, Mihan Pourabdollah3, Johan Garssen4, Payam Tabarsi1, Aliakbar Velayati5, Ian M Adcock6.   

Abstract

BACKGROUND: Sarcoidosis is a granulomatous disease of unknown etiology. Macrophages play a key role in granuloma formation with the T cells, having a significant impact on macrophage polarization (M1 and M2) and the cellular composition of the granuloma. This study evaluates macrophage polarization in granulomas in pulmonary sarcoidosis.
MATERIALS AND METHODS: Tissue specimens from the Department of Pathology biobank at the Masih Daneshvari Hospital were obtained. Paraffin sections from 10 sarcoidosis patients were compared with those from 12 cases of tuberculosis using immunohistochemical staining. These sections consisted of mediastinal lymph nodes and transbronchial lung biopsy (TBLB) for sarcoidosis patients versus pleural tissue, neck, axillary lymph nodes and TBLB for tuberculosis patients. The sections were stained for T-cells (CD4+, CD8+) and mature B lymphocytes (CD22+). CD14+ and CD68+ staining was used as a marker of M1 macrophages and CD163+ as a marker for M2 macrophages.
RESULTS: Immunohistochemical staining revealed a 4/1 ratio of CD4+/CD8+ T-cells in sarcoidosis granuloma sections and a 3/1 ratio in tuberculosis sections. There was no significance difference in single CD4+, CD8+, CD22+, CD14+ and CD68+ staining between sarcoidosis and tuberculosis sections. CD163 expression was significantly increased in sarcoidosis sections compared with those from tuberculosis subjects.
CONCLUSION: Enhanced CD163+ staining indicates a shift towards M2 macrophage subsets in granulomas from sarcoidosis patients. Further research is required to determine the functional role of M2 macrophages in the immunopathogenesis of sarcoidosis.
Copyright © 2017 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Macrophages; Sarcoidosis; Th2 cells; Tuberculosis

Mesh:

Substances:

Year:  2017        PMID: 29107084     DOI: 10.1016/j.humimm.2017.10.009

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  22 in total

1.  Macrophage Polarization in Sarcoidosis: An Unexpected Accomplice?

Authors:  Theodore J Standiford
Journal:  Am J Respir Cell Mol Biol       Date:  2019-01       Impact factor: 6.914

Review 2.  Emerging insights in sarcoidosis: moving forward through reverse translational research.

Authors:  Angela Liu; Lokesh Sharma; Xiting Yan; Charles S Dela Cruz; Erica L Herzog; Changwan Ryu
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2022-02-23       Impact factor: 5.464

Review 3.  Basophils in antihelminth immunity.

Authors:  Jianya Peng; Mark C Siracusa
Journal:  Semin Immunol       Date:  2021-11-21       Impact factor: 11.130

4.  Research on the mechanism of berberine in the treatment of COVID-19 pneumonia pulmonary fibrosis using network pharmacology and molecular docking.

Authors:  Junfeng Cao; Lianglei Li; Li Xiong; Chaochao Wang; Yijun Chen; Xiao Zhang
Journal:  Phytomed Plus       Date:  2022-03-04

5.  Impaired mitochondrial function of alveolar macrophages in carbon nanotube-induced chronic pulmonary granulomatous disease.

Authors:  Eman Soliman; Ahmed E M Elhassanny; Anagha Malur; Matthew McPeek; Aaron Bell; Nancy Leffler; Rukiyah Van Dross; Jacob L Jones; Achut G Malur; Mary Jane Thomassen
Journal:  Toxicology       Date:  2020-09-22       Impact factor: 4.221

6.  Single-cell RNA sequencing identifies macrophage transcriptional heterogeneities in granulomatous diseases.

Authors:  Shu-Yi Liao; Shaikh M Atif; Kara Mould; Iain R Konigsberg; Rui Fu; Elizabeth Davidson; Li Li; Andrew P Fontenot; Lisa A Maier; Ivana V Yang
Journal:  Eur Respir J       Date:  2021-06-17       Impact factor: 16.671

Review 7.  Clinical Presentations, Pathogenesis, and Therapy of Sarcoidosis: State of the Art.

Authors:  Francesca Polverino; Elisabetta Balestro; Paolo Spagnolo
Journal:  J Clin Med       Date:  2020-07-24       Impact factor: 4.241

8.  Dissecting the target leukocyte subpopulations of clinically relevant inflammation radiopharmaceuticals.

Authors:  Tobias Borchert; Laura Beitar; Laura B N Langer; Andras Polyak; Hans-Jürgen Wester; Tobias L Ross; Denise Hilfiker-Kleiner; Frank M Bengel; James T Thackeray
Journal:  J Nucl Cardiol       Date:  2019-10-28       Impact factor: 5.952

Review 9.  Targeting of CD163+ Macrophages in Inflammatory and Malignant Diseases.

Authors:  Maria K Skytthe; Jonas Heilskov Graversen; Søren K Moestrup
Journal:  Int J Mol Sci       Date:  2020-07-31       Impact factor: 5.923

10.  Human genetic variation in GLS2 is associated with development of complicated Staphylococcus aureus bacteremia.

Authors:  William K Scott; Felix Mba Medie; Felicia Ruffin; Batu K Sharma-Kuinkel; Derek D Cyr; Shengru Guo; Derek M Dykxhoorn; Robert L Skov; Niels E Bruun; Anders Dahl; Christian J Lerche; Andreas Petersen; Anders Rhod Larsen; Trine Kiilerich Lauridsen; Helle Krogh Johansen; Henrik Ullum; Erik Sørensen; Christian Hassager; Henning Bundgaard; Henrik C Schønheyder; Christian Torp-Pedersen; Louise Bruun Østergaard; Magnus Arpi; Flemming Rosenvinge; Lise T Erikstrup; Mahtab Chehri; Peter Søgaard; Paal S Andersen; Vance G Fowler
Journal:  PLoS Genet       Date:  2018-10-05       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.